Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis (Q33407924)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis |
scientific article |
Statements
1 reference
Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis (English)
1 reference
Ayalew Tefferi
1 reference
Daniel J DeAngelo
1 reference
Ruben A Mesa
1 reference
Warren Fiskus
1 reference
Carole Paley
1 reference
Ellen K Ritchie
1 reference
David S Snyder
1 reference
Kebede Begna
1 reference
Siddhartha Ganguly
1 reference
Michael S Ondovik
1 reference
Jessica Rine
1 reference
Kapil N Bhalla
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference